| Product ID | 72065-141_ce185945-5954-c1b3-e053-2a95a90a8908 |
| NDC | 72065-141 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Gvoke Kit Vial |
| Generic Name | Glucagon Injection, Solution |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2021-10-11 |
| Marketing Category | NDA / |
| Application Number | NDA212097 |
| Labeler Name | Xeris Pharmaceuticals, Inc. |
| Substance Name | GLUCAGON |
| Active Ingredient Strength | 1 mg/.2mL |
| Pharm Classes | Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |